ACRDF
Price
$0.14
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
110 days until earnings call
TSMRF
Price
$28.15
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

ACRDF vs TSMRF

Header iconACRDF vs TSMRF Comparison
Open Charts ACRDF vs TSMRFBanner chart's image
Acreage Holdings
Price$0.14
Change-$0.00 (-0.00%)
Volume$1.56K
CapitalizationN/A
Tsumura & Co
Price$28.15
Change-$0.00 (-0.00%)
Volume$100
CapitalizationN/A
ACRDF vs TSMRF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ACRDF vs. TSMRF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRDF is a Hold and TSMRF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (ACRDF: $0.14 vs. TSMRF: $28.15)
Brand notoriety: ACRDF and TSMRF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACRDF: 7% vs. TSMRF: 23%
Market capitalization -- ACRDF: $30.63M vs. TSMRF: $1.44B
ACRDF [@Pharmaceuticals: Other] is valued at $30.63M. TSMRF’s [@Pharmaceuticals: Other] market capitalization is $1.44B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRDF’s FA Score shows that 0 FA rating(s) are green whileTSMRF’s FA Score has 1 green FA rating(s).

  • ACRDF’s FA Score: 0 green, 5 red.
  • TSMRF’s FA Score: 1 green, 4 red.
According to our system of comparison, TSMRF is a better buy in the long-term than ACRDF.

Price Growth

ACRDF (@Pharmaceuticals: Other) experienced а -35.45% price change this week, while TSMRF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.99%. For the same industry, the average monthly price growth was -7.80%, and the average quarterly price growth was -7.77%.

Reported Earning Dates

ACRDF is expected to report earnings on Mar 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.99% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
TSMRF($1.44B) has a higher market cap than ACRDF($30.6M). TSMRF YTD gains are higher at: 55.525 vs. ACRDF (-43.200). TSMRF has higher annual earnings (EBITDA): 37B vs. ACRDF (-120.14M). TSMRF has more cash in the bank: 93.7B vs. ACRDF (14.3M). ACRDF has less debt than TSMRF: ACRDF (240M) vs TSMRF (79.7B). TSMRF has higher revenues than ACRDF: TSMRF (138B) vs ACRDF (236M).
ACRDFTSMRFACRDF / TSMRF
Capitalization30.6M1.44B2%
EBITDA-120.14M37B-0%
Gain YTD-43.20055.525-78%
P/E RatioN/A12.64-
Revenue236M138B0%
Total Cash14.3M93.7B0%
Total Debt240M79.7B0%
FUNDAMENTALS RATINGS
TSMRF: Fundamental Ratings
TSMRF
OUTLOOK RATING
1..100
43
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
77
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

ACRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRDF has been loosely correlated with ACRHF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRDF jumps, then ACRHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRDF
1D Price
Change %
ACRDF100%
-25.24%
ACRHF - ACRDF
33%
Loosely correlated
+0.75%
ORGO - ACRDF
20%
Poorly correlated
-9.59%
CRYM - ACRDF
13%
Poorly correlated
+18.93%
TCNNF - ACRDF
9%
Poorly correlated
-6.28%
TSMRF - ACRDF
6%
Poorly correlated
N/A
More

TSMRF and

Correlation & Price change

A.I.dvisor tells us that TSMRF and ACB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TSMRF and ACB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSMRF
1D Price
Change %
TSMRF100%
N/A
ACB - TSMRF
30%
Poorly correlated
-4.41%
HNSPF - TSMRF
29%
Poorly correlated
N/A
GEDSF - TSMRF
22%
Poorly correlated
N/A
TLRY - TSMRF
22%
Poorly correlated
-4.17%
CGC - TSMRF
21%
Poorly correlated
-5.08%
More